rs4126690
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001205293.3(CACNA1E):c.512+3897G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.265 in 152,036 control chromosomes in the GnomAD database, including 5,951 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.26 ( 5951 hom., cov: 32)
Consequence
CACNA1E
NM_001205293.3 intron
NM_001205293.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.582
Publications
5 publications found
Genes affected
CACNA1E (HGNC:1392): (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
CACNA1E Gene-Disease associations (from GenCC):
- developmental and epileptic encephalopathy, 69Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- neurodevelopmental disorderInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.391 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1E | ENST00000367573.7 | c.512+3897G>T | intron_variant | Intron 3 of 47 | 1 | NM_001205293.3 | ENSP00000356545.2 | |||
| CACNA1E | ENST00000360108.7 | c.512+3897G>T | intron_variant | Intron 3 of 46 | 5 | ENSP00000353222.3 | ||||
| CACNA1E | ENST00000367570.6 | c.512+3897G>T | intron_variant | Intron 3 of 46 | 1 | ENSP00000356542.1 | ||||
| CACNA1E | ENST00000621791.4 | c.512+3897G>T | intron_variant | Intron 3 of 45 | 1 | ENSP00000481619.1 | ||||
| CACNA1E | ENST00000524607.6 | c.947+3897G>T | intron_variant | Intron 5 of 11 | 5 | ENSP00000432038.2 |
Frequencies
GnomAD3 genomes AF: 0.264 AC: 40169AN: 151918Hom.: 5931 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
40169
AN:
151918
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.265 AC: 40220AN: 152036Hom.: 5951 Cov.: 32 AF XY: 0.268 AC XY: 19894AN XY: 74314 show subpopulations
GnomAD4 genome
AF:
AC:
40220
AN:
152036
Hom.:
Cov.:
32
AF XY:
AC XY:
19894
AN XY:
74314
show subpopulations
African (AFR)
AF:
AC:
15920
AN:
41424
American (AMR)
AF:
AC:
3727
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
590
AN:
3466
East Asian (EAS)
AF:
AC:
746
AN:
5176
South Asian (SAS)
AF:
AC:
1955
AN:
4818
European-Finnish (FIN)
AF:
AC:
2295
AN:
10562
Middle Eastern (MID)
AF:
AC:
83
AN:
292
European-Non Finnish (NFE)
AF:
AC:
14130
AN:
67994
Other (OTH)
AF:
AC:
547
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1458
2917
4375
5834
7292
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
406
812
1218
1624
2030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
922
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.